Advanced lung adenocarcinoma (LUAD) patient with EGFR mutations benefited from multiline combination targeted therapies after osimertinib (AZD9291) resistance: a case report
-
Published:2022-09
Issue:9
Volume:11
Page:3343-3348
-
ISSN:2218-676X
-
Container-title:Translational Cancer Research
-
language:
-
Short-container-title:Transl Cancer Res TCR
Author:
Chen Jingyu,Zhao Xueqi,Wang Jinlin,Liu Fangfang,Zhang Linli,Chen Yuan,Chu Qian
Publisher
AME Publishing Company
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Multiple drug;Reactions Weekly;2023-07-01